Company profilePharmaceutical#807 of 1,318 in Pakistan✓ No DRAP alerts

Lakhani Pharma (Pvt.) Limited DML: 000928

Pharmaceutical company · 9 brands · 12 molecules

9 registered products 19 pharmaceutical brands 12 distinct molecules 0 DRAP alerts

Company overview

9
registered products
19
pharmaceutical brands
12
distinct molecules
0
therapeutic classes
0
DRAP alerts

Lakhani Pharma (Pvt.) Limited DML: 000928 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 9 product registrations across 12 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Lakhani

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20261

Top molecules by brand count

Chloride4 brands
Calcium2 brands
Sterile Water For Injection ...... 20 Ml1 brand
Sterile Water For Injection ...... 5 Ml1 brand
Sterile Water For Injection ...... 10 Ml1 brand
Calcium Chloride ...... 0.02 G1 brand
Potassium Chloride ...... 0.0746 G1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official6 products · Rs 17.61 – Rs 1,555.83
Median across source: Rs 128.39

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Lakhani Pharma (Pvt.) Limited holds 5 molecules not in this portfolio
GlucoseMetronidazolePotassium ChlorideSodium ChlorideSterile Water For Injection
Unisa Pharmaceutical Industries Limited DML: 000740 holds 2 molecules not in this portfolio
LevofloxacinMannitol
Atco Pharma International (Pvt) Ltd holds 232 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline

Get the full profile for Lakhani

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.